Email Newsletters

Boston Scientific Corp.

Coronavirus’ financial impact hitting Central Mass.

Central Massachusetts businesses with broad geographic reaches are feeling the effects of the spread of coronavirus.

Boston Scientific wins FDA clearance for single-use endoscope

Boston Scientific has won regulatory clearance for what it says is the first disposable duodenoscope, a device inserted through the mouth so doctors can look into the small intestine.

🔒Visa program used by Central Mass. businesses for specialized workers under fire

When Central Massachusetts companies look to fill software, programming or research jobs, they’re increasingly looking to foreign labor under an immigrant work program called H-1B.

Boston Scientific stock jumps on $126M profit report

Marlborough medical device giant Boston Scientific’s stocks rose 6% Wednesday morning after the company reported a $126-million profit on $2.7 billion in sales for the third quarter, exceeding the company’s guidance range for sales.
- Advertisement -

Boston hospital president to join Boston Scientific

Marlborough medical company Boston Scientific announced Tuesday that Michael Jaff will join the company as the vice president for clinical affairs, innovation and technology, peripheral interventions by January 2020.

FDA approves Boston Scientific’s brain stimulation system

The U.S. Food and Drug Administration has approved Boston Scientific’s new imaging tool to be used with a deep brain stimulation device. 

Boston Scientific closes $4B acquisition of U.K. firm BTG

Boston Scientific has closed on its $4-billion acquisition of U.K.-based cancer firm BTG nearly two weeks after U.S. trade regulators signed off on the deal. 

Boston Scientific sells microsphere biz for $90M ahead of $4.2B merger

Marlborough biomanufacturing firm Boston Scientific is selling its drug-loadable microsphere business to a California biotech firm for $90 million.
- Advertisement -

Boston Scientific closes on $465M purchase of Calif. biotech

Boston Scientific has closed on the $465-million acquisition of a California biotech about a month after announcing the deal that bolster’s the Marlborough medical device giant’s pain management offerings.

Boston Scientific launches irregular heartbeat device study

Boston Scientific has begun a trial to compare the safety and effectiveness of the next generation of one of its flagship atrial fibrillation devices.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Quality Engineer II – Columbia Tech

Columbia Tech
,
Westborough, MA

Retail and Customer Service Specialist

Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$20/hour

Chief Financial Officer

The Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$125,000 - $135,000
More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA